Heidi Ko, Medical Director, Medical Affairs at Labcorp Drug Development, shared on LinkedIn:
“Today marks my last day at Labcorp, and it’s truly a mix of emotions.
I’m incredibly proud of what we accomplished together from developing medical education programs, presenting at national and international conferences, contributing to various publications in precision medicine, and leading MRD studies that helped strengthen the evidence needed to support clinical adoption and patient access to innovative diagnostics.
Beyond the professional milestones, this chapter was especially meaningful because I also welcomed my son during my time. I’ll always be thankful for the encouragement, flexibility, and support I received from my colleagues!
As I begin my next chapter, I’m excited to build on my passion for translating emerging science into meaningful clinical impact and helping make innovative therapies accessible to the patients who need them most, something my grandma and so many others in my country growing up never had.
To everyone at Labcorp and to all of the colleagues, collaborators, and friends I’ve had the privilege to work with, thank you! I’ll always be grateful for this chapter and excited for what’s ahead.”
